Barrett J C
Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.
Mutat Res. 1995 Dec;333(1-2):189-202. doi: 10.1016/0027-5107(95)00145-x.
Species differences resulting from a number of mechanisms are common in receptor-mediated chemical carcinogenesis. In this review, examples of possible mechanisms underlying these differences are discussed, including ligand metabolism, receptor polymorphisms, receptor isoforms, receptor levels, and crosstalk between signal transduction pathways. In addition, a number of other mechanisms also are likely to be important. The developmental state of the animal will determine the expression of receptors in different tissues. The regulatory pathways for cell proliferation and cell death and cell cycle check point controls can vary among species and tissues. Adaptation or potentiation of responses during chronic exposures to chemicals can greatly influence species differences. The mechanisms of adaptive processes are poorly understood but probably highly important for chronic toxicities such as cancer. Finally, different species may have different stem cell populations that are the targets for neoplastic transformation, and this will influence receptor-mediated carcinogenic responses. The implications of species differences in receptor-mediated responses for risk assessment are discussed.
由多种机制导致的物种差异在受体介导的化学致癌过程中很常见。在本综述中,将讨论这些差异背后可能机制的实例,包括配体代谢、受体多态性、受体亚型、受体水平以及信号转导途径之间的相互作用。此外,许多其他机制可能也很重要。动物的发育状态将决定不同组织中受体的表达。细胞增殖、细胞死亡和细胞周期检查点控制的调节途径在不同物种和组织之间可能有所不同。长期接触化学物质期间反应的适应性或增强作用会极大地影响物种差异。适应性过程的机制了解甚少,但可能对诸如癌症等慢性毒性非常重要。最后,不同物种可能有不同的干细胞群体作为肿瘤转化的靶点,这将影响受体介导的致癌反应。文中讨论了受体介导反应中的物种差异对风险评估的影响。